Collection of Samples From the United States Population for Optimization and Evaluation of Colorectal Cancer (CRC) Plasma Circulating Free-DNA (cfDNA) Marker Panel Performance

Recruiting now

Conditions studied: Colorectal Cancer

In brief

This study is designed to prospectively collect blood samples and clinical data from patients that have been newly diagnosed with colorectal cancer and scheduled for resection surgery but are pre cancer treatment, subjects who are NOT scheduled for surgery but have histological confirmation of CRC from the diagnostic colonoscopy and clinical staging (cTMN) is available and are pr e- treatment, and patients who are at average risk of colorectal cancer and who are scheduled for routine colonoscopy examinations.

Key facts

Study ID

NCT07310446

Run by

Universal Diagnostics

People needed

6500

Starts

2023-07-31

Expected to finish

2027-07-01

Last updated by the study team

2025-12-30

Who can join

Age: 45 and older, up to 84. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Arm A: Diagnosed with CRC
• Arm B: Undergoing screening with colonoscopy for CRC

You may not qualify if…

• Arm A: Undergoing treatment for CRC,
• Arm B: Past history of CRC

Where it is running

• Gastroenterology and Internal Medicine Specialists — Lake Barrington, Illinois, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.